515 related articles for article (PubMed ID: 35563159)
1. Role of Short-Chain Fatty Acids Produced by Gut Microbiota in Innate Lung Immunity and Pathogenesis of the Heterogeneous Course of Chronic Obstructive Pulmonary Disease.
Kotlyarov S
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563159
[TBL] [Abstract][Full Text] [Related]
2. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases.
Ashique S; De Rubis G; Sirohi E; Mishra N; Rihan M; Garg A; Reyes RJ; Manandhar B; Bhatt S; Jha NK; Singh TG; Gupta G; Singh SK; Chellappan DK; Paudel KR; Hansbro PM; Oliver BG; Dua K
Chem Biol Interact; 2022 Dec; 368():110231. PubMed ID: 36288778
[TBL] [Abstract][Full Text] [Related]
3. Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease.
Shin Y; Han S; Kwon J; Ju S; Choi TG; Kang I; Kim SS
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892541
[TBL] [Abstract][Full Text] [Related]
4. The Bufei Jianpi Formula Improves Mucosal Immune Function by Remodeling Gut Microbiota Through the SCFAs/GPR43/NLRP3 Pathway in Chronic Obstructive Pulmonary Disease Rats.
Mao J; Li Y; Bian Q; Xuan Y; Li J; Wang Z; Feng S; Liu X; Tian Y; Li S
Int J Chron Obstruct Pulmon Dis; 2022; 17():1285-1298. PubMed ID: 35673595
[TBL] [Abstract][Full Text] [Related]
5. Microbiome Links Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease and Dietary Fiber via the Gut-Lung Axis: A Narrative Review.
Ding K; Chen J; Zhan W; Zhang S; Chen Y; Long S; Lei M
COPD; 2021 Dec; 19(1):10-17. PubMed ID: 34963421
[TBL] [Abstract][Full Text] [Related]
6. Seabuckthorn Wuwei Pulvis attenuates chronic obstructive pulmonary disease in rat through gut microbiota-short chain fatty acids axis.
Wang J; Ren C; Jin L; Batu W
J Ethnopharmacol; 2023 Oct; 314():116591. PubMed ID: 37146846
[TBL] [Abstract][Full Text] [Related]
7. Anticancer Effects of Gut Microbiota-Derived Short-Chain Fatty Acids in Cancers.
Son MY; Cho HS
J Microbiol Biotechnol; 2023 Jul; 33(7):849-856. PubMed ID: 37100764
[TBL] [Abstract][Full Text] [Related]
8. The gut-lung axis in severe acute Pancreatitis-associated lung injury: The protection by the gut microbiota through short-chain fatty acids.
Wang Z; Liu J; Li F; Luo Y; Ge P; Zhang Y; Wen H; Yang Q; Ma S; Chen H
Pharmacol Res; 2022 Aug; 182():106321. PubMed ID: 35752356
[TBL] [Abstract][Full Text] [Related]
9. Butyrate inhibits iILC2-mediated lung inflammation via lung-gut axis in chronic obstructive pulmonary disease (COPD).
Jiang M; Li Z; Zhang F; Li Z; Xu D; Jing J; Li F; Wang J; Ding J
BMC Pulm Med; 2023 May; 23(1):163. PubMed ID: 37173731
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota-derived short-chain fatty acids regulate gastrointestinal tumor immunity: a novel therapeutic strategy?
Dong Y; Zhang K; Wei J; Ding Y; Wang X; Hou H; Wu J; Liu T; Wang B; Cao H
Front Immunol; 2023; 14():1158200. PubMed ID: 37122756
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).
Ratajczak W; Rył A; Mizerski A; Walczakiewicz K; Sipak O; Laszczyńska M
Acta Biochim Pol; 2019 Mar; 66(1):1-12. PubMed ID: 30831575
[TBL] [Abstract][Full Text] [Related]
12. Short-chain fatty acids inhibit the activation of T lymphocytes and myeloid cells and induce innate immune tolerance.
Porbahaie M; Hummel A; Saouadogo H; Coelho RML; Savelkoul HFJ; Teodorowicz M; van Neerven RJJ
Benef Microbes; 2023 Sep; 14(4):401-419. PubMed ID: 38661366
[TBL] [Abstract][Full Text] [Related]
13. Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis.
Sivaprakasam S; Prasad PD; Singh N
Pharmacol Ther; 2016 Aug; 164():144-51. PubMed ID: 27113407
[TBL] [Abstract][Full Text] [Related]
14. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
[TBL] [Abstract][Full Text] [Related]
15. The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: Mechanisms and therapeutic potentials.
Duan H; Wang L; Huangfu M; Li H
Biomed Pharmacother; 2023 Sep; 165():115276. PubMed ID: 37542852
[TBL] [Abstract][Full Text] [Related]
16. Role of microbiota short-chain fatty acids in the pathogenesis of autoimmune diseases.
Rasouli-Saravani A; Jahankhani K; Moradi S; Gorgani M; Shafaghat Z; Mirsanei Z; Mehmandar A; Mirzaei R
Biomed Pharmacother; 2023 Jun; 162():114620. PubMed ID: 37004324
[TBL] [Abstract][Full Text] [Related]
17. Short chain fatty acids: Microbial metabolites for gut-brain axis signalling.
O'Riordan KJ; Collins MK; Moloney GM; Knox EG; Aburto MR; Fülling C; Morley SJ; Clarke G; Schellekens H; Cryan JF
Mol Cell Endocrinol; 2022 Apr; 546():111572. PubMed ID: 35066114
[TBL] [Abstract][Full Text] [Related]
18. The Immunomodulatory Potential of Short-Chain Fatty Acids in Multiple Sclerosis.
Barcutean L; Maier S; Burai-Patrascu M; Farczadi L; Balasa R
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542172
[TBL] [Abstract][Full Text] [Related]
19. The emerging role of microbiota-derived short-chain fatty acids in immunometabolism.
Abdalkareem Jasim S; Jade Catalan Opulencia M; Alexis Ramírez-Coronel A; Kamal Abdelbasset W; Hasan Abed M; Markov A; Raheem Lateef Al-Awsi G; Azamatovich Shamsiev J; Thaeer Hammid A; Nader Shalaby M; Karampoor S; Mirzaei R
Int Immunopharmacol; 2022 Sep; 110():108983. PubMed ID: 35750016
[TBL] [Abstract][Full Text] [Related]
20. Are Short Chain Fatty Acids in Gut Microbiota Defensive Players for Inflammation and Atherosclerosis?
Ohira H; Tsutsui W; Fujioka Y
J Atheroscler Thromb; 2017 Jul; 24(7):660-672. PubMed ID: 28552897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
